ecancer

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

12 Oct 2016

Comment: Niraparib for ovarian cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

10 Oct 2016

Outcome of ovarian cancer patients was significantly improved with niraparib

Dr Mansoor Raza Mirza - Copenhagen University Hospital, Copenhagen, Denmark

8 Oct 2016

Niraparib significantly improves outcomes for ovarian cancer patients

Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark

8 Oct 2016

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK

5 Oct 2016

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

22 Aug 2016

Review of olaparib for ovarian cancer

Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

A global perspective on infections related to cancer

Dr Silvia Franceschi - IARC, Lyon, France

1 Jul 2016

Breast and cervical cancer rates influenced by HRT, not contraceptive pill

Prof Valerie Beral - University of Oxford, Oxford, UK

30 Jun 2016

Monitoring HPV vaccination program impact in Bhutan and Rwanda

Dr Gary Clifford - IARC, Lyon, France

30 Jun 2016

More from ecancer